Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Challenges in αCD38-chimeric antigen receptor (CAR)-expressing natural killer (NK) cell-based immunotherapy in multiple myeloma: Harnessing the CD38dim phenotype of cytokine-stimulated NK cells as a strategy to prevent fratricide.
Karvouni M, Vidal-Manrique M, Susek KH, Hussain A, Gilljam M, Zhang Y, Gray JD, Lund J, Kaufmann G, Ljunggren HG, Ji H, Lundqvist A, Wagner AK, Guo W, Alici E. Karvouni M, et al. Among authors: alici e. Cytotherapy. 2023 Jul;25(7):763-772. doi: 10.1016/j.jcyt.2023.03.006. Epub 2023 Apr 11. Cytotherapy. 2023. PMID: 37055320 Free article.
The prognostic significance of 8p21 deletion in multiple myeloma.
Sutlu T, Alici E, Jansson M, Wallblom A, Dilber MS, Gahrton G, Nahi H. Sutlu T, et al. Among authors: alici e. Br J Haematol. 2009 Jan;144(2):266-8. doi: 10.1111/j.1365-2141.2008.07454.x. Epub 2008 Nov 11. Br J Haematol. 2009. PMID: 19016723 Free article. No abstract available.
NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy.
Malmberg KJ, Bryceson YT, Carlsten M, Andersson S, Björklund A, Björkström NK, Baumann BC, Fauriat C, Alici E, Dilber MS, Ljunggren HG. Malmberg KJ, et al. Among authors: alici e. Cancer Immunol Immunother. 2008 Oct;57(10):1541-52. doi: 10.1007/s00262-008-0492-7. Epub 2008 Mar 4. Cancer Immunol Immunother. 2008. PMID: 18317755 Free PMC article. Review.
Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study.
Barkholt L, Alici E, Conrad R, Sutlu T, Gilljam M, Stellan B, Christensson B, Guven H, Björkström NK, Söderdahl G, Cederlund K, Kimby E, Aschan J, Ringdén O, Ljunggren HG, Dilber MS. Barkholt L, et al. Among authors: alici e. Immunotherapy. 2009 Sep;1(5):753-64. doi: 10.2217/imt.09.47. Immunotherapy. 2009. PMID: 20636021 Clinical Trial.
113 results